S
WST icon

SignatureFD’s West Pharmaceutical WST Stock Holding History

SignatureFD’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Buy
941
+265
+39% +$81K ﹤0.01% 834
2026
Q1 		$169K Sell
676
-173
-20% -$43K ﹤0.01% 1093
2025
Q4 		$234K Buy
849
+33
+4% +$9.03K ﹤0.01% 881
2025
Q3 		$214K Buy
816
+82
+11% +$19.9K ﹤0.01% 929
2025
Q2 		$161K Sell
734
-385
-34% -$82.3K ﹤0.01% 1012
2025
Q1 		$251K Buy
1,119
+139
+14% +$38.3K ﹤0.01% 786
2024
Q4 		$321K Buy
980
+88
+10% +$27.7K 0.01% 696
2024
Q3 		$268K Sell
892
-46
-5% -$14.1K 0.01% 738
2024
Q2 		$309K Sell
938
-68
-7% -$24K 0.01% 655
2024
Q1 		$398K Buy
1,006
+90
+10% +$33.3K 0.01% 587
2023
Q4 		$323K Sell
916
-62
-6% -$21.9K 0.01% 621
2023
Q3 		$367K Buy
978
+74
+8% +$28.6K 0.01% 539
2023
Q2 		$346K Buy
904
+5
+0.6% +$1.79K 0.01% 572
2023
Q1 		$311K Buy
899
+222
+33% +$64.9K 0.01% 586
2022
Q4 		$159K Buy
677
+146
+27% +$34.6K ﹤0.01% 789
2022
Q3 		$131K Sell
531
-249
-32% -$75.9K ﹤0.01% 835
2022
Q2 		$236K Sell
780
-43
-5% -$14K 0.01% 637
2022
Q1 		$338K Buy
823
+6
+0.7% +$2.35K 0.01% 540
2021
Q4 		$383K Buy
817
+207
+34% +$89.1K 0.01% 482
2021
Q3 		$259K Buy
610
+139
+30% +$58.6K 0.01% 589
2021
Q2 		$169K Buy
471
+131
+39% +$43.3K 0.01% 735
2021
Q1 		$96K Buy
340
+45
+15% +$12.9K ﹤0.01% 896
2020
Q4 		$84K Buy
295
+63
+27% +$17.7K ﹤0.01% 858
2020
Q3 		$64K Buy
232
+83
+56% +$22K ﹤0.01% 873
2020
Q2 		$34K Buy
149
+48
+48% +$9.43K ﹤0.01% 1115
2020
Q1 		$15K Buy
101
+77
+321% +$11.9K ﹤0.01% 1355
2019
Q4 		$4K Buy
+24
New +$3.49K ﹤0.01% 1725
2016
Q1 		– Sell
-22
Closed -$1K – 1457
2015
Q4 		$1K Hold
22
– – ﹤0.01% 1235
2015
Q3 		$1K Buy
+22
New +$1.28K ﹤0.01% 1170

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SignatureFD's WST Position: Q2 2026 in Review

SignatureFD increased its West Pharmaceutical (WST) stake by 39% in Q2 2026, buying an estimated $81K and bringing the position to 941 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #834.

SignatureFD first reported a position in WST in Q3 2015 and has held it in 29 quarters since. The position peaked at $398K in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • SignatureFD held 941 shares of West Pharmaceutical worth $338K as of Q2 2026.
  • SignatureFD bought 265 West Pharmaceutical shares in Q2 2026, an estimated $81K.
  • West Pharmaceutical made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #834 holding.
  • SignatureFD first reported a position in West Pharmaceutical in Q3 2015 and has held it in 29 quarters since.
  • SignatureFD's West Pharmaceutical position peaked at $398K in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.